Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 15;41(18):3449-3465.
doi: 10.1002/sim.9427. Epub 2022 Jun 8.

Toward evaluation of disseminated effects of medications for opioid use disorder within provider-based clusters using routinely-collected health data

Affiliations

Toward evaluation of disseminated effects of medications for opioid use disorder within provider-based clusters using routinely-collected health data

Ashley Buchanan et al. Stat Med. .

Abstract

Routinely-collected health data can be employed to emulate a target trial when randomized trial data are not available. Patients within provider-based clusters likely exert and share influence on each other's treatment preferences and subsequent health outcomes and this is known as dissemination or spillover. Extending a framework to replicate an idealized two-stage randomized trial using routinely-collected health data, an evaluation of disseminated effects within provider-based clusters is possible. In this article, we propose a novel application of causal inference methods for dissemination to retrospective cohort studies in administrative claims data and evaluate the impact of the normality of the random effects distribution for the cluster-level propensity score on estimation of the causal parameters. An extensive simulation study was conducted to study the robustness of the methods under different distributions of the random effects. We applied these methods to evaluate baseline prescription for medications for opioid use disorder among a cohort of patients diagnosed with opioid use disorder and adjust for baseline confounders using information obtained from an administrative claims database. We discuss future research directions in this setting to better address unmeasured confounding in the presence of disseminated effects.

Keywords: dissemination; health data; interference; medication for opioid use disorder; mixed effects models; opioid use disorder.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Schematic diagram of the subsets of data used for each estimator (direct, disseminated, composite, and overall) based on a format provided in Halloran and Struchiner
FIGURE 2
FIGURE 2
Schematic diagram of retrospective cohort study of medications for opioid use disorder (MOUD) on the two-year risk of opioid overdose among patients diagnosed with opioid use disorder (OUD) in Optum’s de-identified Clinformatics® Data Mart Database, 2010-2017, United States

Similar articles

Cited by

References

    1. Chilcoat HD, Amick HR, Sherwood MR, Dunn KE. Buprenorphine in the United States: Motives for abuse, misuse, and diversion. Journal of Substance Abuse Treatment 2019; 104: 148–157. - PubMed
    1. Cooper HL, Cloud DH, Young AM, Freeman PR. When Prescribing Isn’t Enough-Pharmacy-Level Barriers to Buprenorphine Access. The New England Journal of Medicine 2020; 383(8): 703–705. - PubMed
    1. Christakis NA. Social networks and collateral health effects. BMJ 2004; 329(7459): 184–185. - PMC - PubMed
    1. Friedman SR, Maslow C, Bolyard M, Sandoval M, Mateu-Gelabert P, Neaigus A. Urging others to be healthy:“Intravention” by injection drug users as a community prevention goal. AIDS Education and Prevention 2004; 16(3): 250–263. - PubMed
    1. Mateu-Gelabert P, Guarino H, Quinn K, et al. Young drug users: A vulnerable population and an underutilized resource in HIV/HCV prevention. Current HIV/AIDS Reports 2018; 15(4): 324–335. - PMC - PubMed

Publication types

LinkOut - more resources